IPCA Laboratories Ltd
NSE:IPCALAB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 058.6
1 703.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
IPCA Laboratories Ltd
Wall Street
Price Targets
IPCALAB Price Targets Summary
IPCA Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
IPCALAB
is 1 614.59 INR
with a low forecast of 960.51 INR and a high forecast of 2 026.5 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
IPCA Laboratories Ltd
For the last 8 years the
compound annual growth rate for
IPCA Laboratories Ltd's operating income is
24%.
The projected
CAGR
for the next 3 years is
30%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IPCALAB's stock price target?
Price Target
1 614.59
INR
According to Wall Street analysts, the average 1-year price target for
IPCALAB
is 1 614.59 INR
with a low forecast of 960.51 INR and a high forecast of 2 026.5 INR.
What is IPCA Laboratories Ltd's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
IPCA Laboratories Ltd's revenue is
13%.
The projected
CAGR
for the next 3 years is
15%.
What is IPCA Laboratories Ltd's Operating Income forecast?
Projected CAGR
30%
For the last 8 years the
compound annual growth rate for
IPCA Laboratories Ltd's operating income is
24%.
The projected
CAGR
for the next 3 years is
30%.
What is IPCA Laboratories Ltd's Net Income forecast?
Projected CAGR
39%
For the last 8 years the
compound annual growth rate for
IPCA Laboratories Ltd's net income is
25%.
The projected
CAGR
for the next 3 years is
39%.
You don't have any saved screeners yet
